How much funding has NEUROGT INC raised?

NEUROGT INC has raised $1.3M in total funding, most recently a Grant round.

When was NEUROGT INC founded?

NEUROGT INC was founded in 2020.

Where is NEUROGT INC headquartered?

NEUROGT INC is headquartered in DURHAM, North Carolina, United States.

What industry is NEUROGT INC in?

NEUROGT INC operates in Biotech, Healthcare.

How many employees does NEUROGT INC have?

NEUROGT INC has 1-10 employees.

NEUROGT INC

Q: Who are NEUROGT INC's investors?

NEUROGT INC's investors include National Institute of Allergy and Infectious Diseases, NIH, National Institutes of Health.

Creating futures through transformative science and sustainable vision.

DURHAM, United States · Founded 2020 · $1.3M raised

Biotech

Healthcare

Headquarters: DURHAM, North Carolina
Employees: 1–10
Founded: 2020
Business Model: B2B

Website: neurogt.com
Total Funding: $1.3M
Last Round: $307K GrantAug 2023
Rounds: 3

About

NeuroGT is a clinical-stage gene therapy company targeting rare neurogenetic diseases affecting the central nervous system and metabolic pathways. Its platform includes AAV9 gene replacement therapy, Antibody Cleaver (AbC) technology for enabling re-dosing, and AAV-mediated extracellular vesicle mRNA delivery. The company focuses on lysosomal storage disorders including Hurler, Hunter, and Sanfilippo syndromes.

Summary

NEUROGT INC is a Biotech company based in DURHAM, United States, founded in 2020. It has raised $1.3M in total across 3 rounds, most recently a $307K Grant round in Aug 2023. Investors include National Institute of Allergy and Infectious Diseases, NIH and National Institutes of Health.